Organization · Venture Capital
Novalis LifeSciences LLC
Novalis LifeSciences LLC is a boutique investment and advisory firm based in the United States, specializing in the life sciences sector. The firm provides venture capital and private equity funding, along with strategic advisory services to companies at critical growth stages.
Overview
What Novalis LifeSciences LLC does
What Novalis LifeSciences LLC is
Novalis LifeSciences LLC is a boutique investment and advisory firm based in the United States, specializing in the life sciences sector. The firm provides venture capital and private equity funding, along with strategic advisory services to companies at critical growth stages.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Novalis LifeSciences LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
Novalis LifeSciences LLC as a funder
Investment thesis
Novalis LifeSciences LLC focuses on investing in the life sciences sector, providing both venture capital and private equity funding to innovative companies in biopharma, diagnostics, and life science tools.
Focus narrative
Novalis LifeSciences invests primarily in the life science tools, diagnostics, and biopharma therapeutics sectors. With a strong focus on growth equity, the firm manages $500 million in assets across three funds, enabling it to provide substantial venture capital and private equity funding to promising companies.
Value beyond capital
Novalis LifeSciences adds value to its portfolio companies through strategic guidance, industry expertise, and access to a network of resources within the life sciences sector. The firm leverages its deep understanding of the market to help companies navigate challenges and accelerate their growth trajectories.
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Sectors
- Biotech · Healthcare · Diagnostics · Pharma Tech
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 17
- Recorded notable exits
- Cerevel Therapeutics, Decipher Biosciences, and Celsee
Portfolio context
Notable portfolio companies include: Cerevel Therapeutics: Focused on treatments for Central Nervous System disorders, acquired by AbbVie in August 2024. Quanterix: Develops sensitive instrumentation for biomolecule analysis, public since December 2017. Decipher Biosciences: Specializes in urological cancer genomics, acquired by Veracyte in March 2021. Celsee: Developed single-cell analysis systems, acquired by Bio-Rad in April 2020. Ginkgo Bioworks: Designs custom microbes for various applications, public since September 2021. Airna: Developing RNA editing therapies for genetic diseases. Animol Discovery: Focused on small molecule discovery for unmet needs in animals. BlueWhale Bio: Developing technology for cell and gene therapy manufacturing. Enko: Agricultural biotechnology company focused on crop protection products. Etherna: Developing next-generation mRNA therapeutics. Flywheel: A medical imaging data platform for healthcare innovation. Helaxy: Provides next-generation sequencing solutions. LevitasBio: Specializes in cellular separation technology. Mercy Bioanalytics: Developing tests for early-stage cancer detection. Ori Biotech: Automating cell and gene therapy manufacturing. Orogen Therapeutics: Small molecule discovery for autoimmune diseases. SkylineDx: Focused on melanoma genomic profiling. Telesis Bio: Provides molecular biology automation solutions. Vigilant Biosciences: Focused on early detection of oral cancer.
Common questions
What to know about Novalis LifeSciences LLC
Upseed classifies Novalis LifeSciences LLC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.